Limited availability of tests to diagnose cancer in its early stages has contributed to an unfortunate prevalence of late-stage diagnoses and metastatic spread. For this reason, emerging technologies that promise early diagnosis constitute a key focus of research. Mid-infrared imaging (MIR), with its ability to enable in vivo medical diagnosis, is particularly interesting. In fact, the European Commission provides support for a major effort to develop the technology through its Framework Seven (FP7) project called MINERVA (MId- to-NEaR- infrared spectroscopy for improVed medical diAgnostics).
|Journal||Laser Focus World|
|Number of pages||4|
|Publication status||Published - 2016|
- CHALCOGENIDE GLASS